Loading
Latest filing published 20 Jun 2025 for Kronos Bio, Inc., €180k. Read the official filing
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
David M. Tanen has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Arno Therapeutics, Inc and Kronos Bio, Inc. The record holds 2 filings, for trades running from 12 January 2016 to 20 June 2025.
On the market, this insider has only ever bought: 1 purchase. No amount is published for 1 filing, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
On 20 June 2025 came the latest disclosure, a transaction for €180k in Kronos Bio, Inc. The last insider purchase was made public on 14 January 2016, 3,929 days ago. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations